Total Payments
$2,061
2021 Payments
$232.61
Companies
22
Transactions
77
Medicare Patients
293
Medicare Billing
$21,795
Payment Breakdown by Category
Food & Beverage$1,910 (92.7%)
Education$150.89 (7.3%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,910 | 74 | 92.7% |
| Education | $150.89 | 3 | 7.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Genentech USA, Inc. | $665.33 | 9 | $0 (2019) |
| GlaxoSmithKline, LLC. | $394.42 | 30 | $0 (2020) |
| Optinose US, Inc. | $232.61 | 1 | $0 (2021) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $128.36 | 3 | $0 (2018) |
| AstraZeneca Pharmaceuticals LP | $105.70 | 7 | $0 (2020) |
| Actelion Pharmaceuticals US, Inc. | $93.52 | 4 | $0 (2020) |
| United Therapeutics Corporation | $89.12 | 2 | $0 (2018) |
| Janssen Pharmaceuticals, Inc | $47.57 | 3 | $0 (2018) |
| Grifols USA, LLC | $45.72 | 2 | $0 (2020) |
| Resmed Corp | $36.67 | 2 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2021 | $232.61 | 1 | Optinose US, Inc. ($232.61) |
| 2020 | $107.00 | 6 | GlaxoSmithKline, LLC. ($26.94) |
| 2019 | $454.13 | 23 | GlaxoSmithKline, LLC. ($153.55) |
| 2018 | $913.66 | 23 | Genentech USA, Inc. ($552.61) |
| 2017 | $353.17 | 24 | GlaxoSmithKline, LLC. ($157.67) |
All Payment Transactions
77 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/16/2021 | Optinose US, Inc. | Xhance (Drug) | Food and Beverage | In-kind items and services | $232.61 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
| 06/22/2020 | AstraZeneca Pharmaceuticals LP | SYMBICORT (Drug) | Food and Beverage | In-kind items and services | $12.93 | General |
| Category: Respiratory | ||||||
| 05/12/2020 | Actelion Pharmaceuticals US, Inc. | UPTRAVI (Drug), OPSUMIT | Food and Beverage | In-kind items and services | $25.28 | General |
| Category: Cardiology | ||||||
| 03/10/2020 | Grifols USA, LLC | Xembify (Biological) | Food and Beverage | In-kind items and services | $24.34 | General |
| Category: Immunology and Neurology | ||||||
| 02/17/2020 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $11.59 | General |
| Category: RESPIRATORY | ||||||
| 01/13/2020 | Resmed Corp | AirCurve (Device) | Food and Beverage | In-kind items and services | $17.51 | General |
| Category: Sleep | ||||||
| 01/06/2020 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $15.35 | General |
| Category: RESPIRATORY | ||||||
| 12/09/2019 | Grifols USA, LLC | Xembify (Biological) | Food and Beverage | In-kind items and services | $21.38 | General |
| Category: Immunology and Neurology | ||||||
| 12/03/2019 | AstraZeneca Pharmaceuticals LP | FASENRA (Drug) | Food and Beverage | In-kind items and services | $15.32 | General |
| Category: Respiratory | ||||||
| 11/18/2019 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $14.07 | General |
| Category: RESPIRATORY | ||||||
| 11/06/2019 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $11.48 | General |
| Category: Respiratory | ||||||
| 10/23/2019 | GlaxoSmithKline, LLC. | — | Food and Beverage | In-kind items and services | $32.34 | General |
| 10/01/2019 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $10.81 | General |
| Category: RESPIRATORY | ||||||
| 09/17/2019 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $23.40 | General |
| Category: RESPIRATORY | ||||||
| 09/10/2019 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $12.69 | General |
| Category: Respiratory | ||||||
| 08/20/2019 | AstraZeneca Pharmaceuticals LP | FASENRA (Drug) | Food and Beverage | In-kind items and services | $17.29 | General |
| Category: Respiratory | ||||||
| 08/14/2019 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $12.30 | General |
| Category: RESPIRATORY | ||||||
| 08/07/2019 | GlaxoSmithKline, LLC. | ANORO (Drug), TRELEGY ELLIPTA | Food and Beverage | In-kind items and services | $12.94 | General |
| Category: RESPIRATORY | ||||||
| 07/31/2019 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $13.10 | General |
| Category: RESPIRATORY | ||||||
| 07/15/2019 | Astellas Pharma US Inc | CRESEMBA (Drug), AMBISOME, MYCAMINE | Food and Beverage | In-kind items and services | $15.36 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 07/08/2019 | Actelion Pharmaceuticals US, Inc. | OPSUMIT (Drug), UPTRAVI | Food and Beverage | In-kind items and services | $29.03 | General |
| Category: Cardiology | ||||||
| 07/01/2019 | Circassia Pharmaceuticals Inc | TUDORZA PRESSAIR (Drug) | Food and Beverage | In-kind items and services | $13.00 | General |
| Category: PULMONARYRESPIRATORY DISEASES | ||||||
| 06/06/2019 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $2.77 | General |
| Category: RESPIRATORY | ||||||
| 04/15/2019 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $23.35 | General |
| Category: RESPIRATORY | ||||||
| 03/27/2019 | Genentech USA, Inc. | Xolair (Biological), Esbriet | Food and Beverage | In-kind items and services | $18.11 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2020 | 8 | 293 | 330 | $85,809 | $21,795 |
Total Patients
293
Total Services
330
Medicare Billing
$21,795
Procedure Codes
8
All Medicare Procedures & Services
8 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 77 | 95 | $30,071 | $7,659 | 25.5% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 89 | 107 | $23,005 | $5,929 | 25.8% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 43 | 43 | $21,027 | $5,099 | 24.2% |
| 94060 | Measurement and graphic recording of the amount and speed of breathed air, before and following medication administration | Office | 2020 | 26 | 26 | $4,420 | $1,124 | 25.4% |
| 94729 | Measurement of lung diffusing capacity | Office | 2020 | 17 | 17 | $2,669 | $732.56 | 27.4% |
| 94727 | Determination of lung volumes using gas dilution or washout | Office | 2020 | 17 | 17 | $2,108 | $576.97 | 27.4% |
| 94618 | Test for exercise-induced lung stress | Office | 2020 | 13 | 14 | $1,442 | $386.01 | 26.8% |
| 94010 | Measurement and graphic recording of total and timed exhaled air capacity | Office | 2020 | 11 | 11 | $1,067 | $288.58 | 27.0% |
About Dr. Eric Freeman, MD
Dr. Eric Freeman, MD is a Pulmonary Disease healthcare provider based in Chesapeake, Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/11/2005. The National Provider Identifier (NPI) number assigned to this provider is 1184626947.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Eric Freeman, MD has received a total of $2,061 in payments from pharmaceutical and medical device companies, with $232.61 received in 2021. These payments were reported across 77 transactions from 22 companies. The most common payment nature is "Food and Beverage" ($1,910).
As a Medicare-enrolled provider, Freeman has provided services to 293 Medicare beneficiaries, totaling 330 services with total Medicare billing of $21,795. Data is available for 1 year (2020–2020), covering 8 distinct procedure/service records.
Ad
Practice Information
- Specialty Pulmonary Disease
- Location Chesapeake, VA
- Active Since 08/11/2005
- Last Updated 02/27/2015
- Taxonomy Code 207RP1001X
- Entity Type Individual
- NPI Number 1184626947
Products in Payments
- Esbriet (Biological) $420.95
- Xhance (Drug) $232.61
- NUCALA (Biological) $153.44
- TRELEGY ELLIPTA (Drug) $95.09
- ORENITRAM (Drug) $89.12
- BREO (Drug) $73.63
- XARELTO (Drug) $47.57
- Xembify (Biological) $45.72
- FASENRA (Drug) $43.40
- ANORO (Drug) $39.92
- OPSUMIT MACITENTAN (Drug) $39.21
- OPSUMIT (Drug) $29.03
- BEVESPI AEROSPHERE (Drug) $26.41
- UPTRAVI (Drug) $25.28
- Adempas (Drug) $25.07
- Arikayce (Drug) $24.17
- XOLAIR (Biological) $22.92
- DUPIXENT (Biological) $22.36
- The Vest System Model 105 Home Care (Device) $21.84
- Astral (Device) $19.16
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pulmonary Disease Doctors in Chesapeake
Carlos Silva, M.d, M.D
Pulmonary Disease — Payments: $281,208
Pulmonary Disease $281,208
Manojkumar Patel, Md, MD
Pulmonary Disease — Payments: $12,628
Pulmonary Disease $12,628
Dr. Haresh Patel, M.d, M.D
Pulmonary Disease — Payments: $3,384
Pulmonary Disease $3,384
Dr. Michelle Perello, Do, DO
Pulmonary Disease — Payments: $3,348
Pulmonary Disease $3,348
Mrs. Vandana Patel, Md, MD
Pulmonary Disease — Payments: $3,037
Pulmonary Disease $3,037
Leah Zuniega, Md, MD
Pulmonary Disease — Payments: $1,988
Pulmonary Disease $1,988